New Active Substances (NAS) LAUNCHED DURING 2018

May 16, 2018

Next up in the Annual Pharma R&D Review, the NAS supplement takes a look at the industry’s victories of 2018 – the drugs launched on to the market for the first time. New entities where the active ingredient had received no prior approval for human use are the focus of this roster of drugs which successfully crossed the finishing line, and lifted the trophy, to become part of pharma’s elite 2018 team.

Spotlight

Gador

Gador is a national capital pharmaceutical company that started its activities in 1940. As a result of sustained growth, Gador is today one of the leading companies in the Argentine market in a wide range of medical specialties, manufacturing its products in its own plants equipped with More high technology and counting on a staff of 850 employees in the country and 120 in the region.

Other Infographics
news image

What Does The Pharma IndustryWant From CROs?

Infographic | June 16, 2022

Use Informa Pharma Intelligence’s marketing and pharma expertise to conduct industry research, produce engaging thought leadership content,

Read More
news image

COVID-19 Summary as of March 13, 2020

Infographic | April 6, 2020

Biomedtracker and Trialtrove have a total of 307 clinical trials for the treatment of COVID-19. 152 initiated trials for the treatment of COVID-19. 155 Trials have been announced but have not yet begun recruitment.

Read More
news image

2021 global life sciences outlook

Infographic | August 24, 2021

The life sciences sector has played a pivotal role amid the COVID-19 pandemic. To cope with the global crisis, traditional competitors partnered to accelerate research and develop the fastest novel vaccine in the history. Governments, health systems, payers, retail pharmacies, and nonprofits are now working collaboratively with the sector to provide widespread distribution and administration.

Read More
news image

Cancer Drugs Bring in Most Pharma Revenue

Infographic | February 25, 2020

Worldwide cancer drug sales are already way ahead of those of other drugs and the revenue generated by them is expected to grow even larger by 2024. This is according to a report recently released by consultancy Evaluate, which analyses trends in the pharmaceutical sector. According to Evaluate's calculations, oncology drugs reached US$123.8 billion in sales in 2018, more than double that of the next item on the list, drugs treating diabetes with US$48.5 billion dollars in sales. By 2024, cancer drug sales are expected to almost double to US$236.6 billion dollars.

Read More
news image

Taking Pharmacy Benefits on a New Ride

Infographic | December 1, 2019

Rideshare companies like Uber and Lyft challenged the old way of doing things with a new approach. It’s not just about getting from point A to point B anymore, it’s about the experience, convenience and added value. The same applies to pass-through PBMs (pharmacy benefit managers) that are challenging the status quo to make prescriptions more affordable..

Read More
news image

Do patients actually watch all those pharma TV ads?

Infographic | January 13, 2020

Fewer than one in eight chronic-disease sufferers say they watch when a drug commercial comes on TV, according to one recent study of community users. And for the millennials among them, the percentage is even less so. That’s despite the $5.1 billion spent by biopharma on the medium in 2018. We take a look at these data points and many others from two recent studies on the media habits of patients and doctors.

Read More

Spotlight

Gador

Gador is a national capital pharmaceutical company that started its activities in 1940. As a result of sustained growth, Gador is today one of the leading companies in the Argentine market in a wide range of medical specialties, manufacturing its products in its own plants equipped with More high technology and counting on a staff of 850 employees in the country and 120 in the region.

Events